PPT-October 2014 Myeloproliferative Neoplasms

Angela Fleischman Division of hematologyOncology MPN are clonal disorders of the hematopoietic stem cell Myelofibrosis MF Hematopoietic stem cell HSC Essential Thrombocythemia ET. October 2014 October 2014 October 2014 October 2014 th. – October 10. th. . Morning Work - RELA. Monday – October 6, 2014. . Demetri came down with the flu on Monday night, and his doctor told him to stay home from school for the rest of the week. She told him that he could do schoolwork on Thursday, but not to overdo it.. MPD. Myeloproliferative. . neoplasms. (MPN) constitute one of five categories of myeloid malignancies, according to the World Health Organization (WHO) classification system for hematopoietic . tumors. 20132014 OFFICERSPresident:Elizabeth LehfeldtVice President:Marc ForsterPast-PresidentSheila olliottExecutive DirectorDonald J. HarreldFinancial OfcerEric NelsonACLS DelegateKathryn A. EdwardsEndow Neoplasm (neo=. new,plasm. =growth). Tumors may be defined as swelling or as a neoplasm. Remember Not all neoplasms form tumors.. Ex: Leukemia (. Leuk. =white, . emia. =blood) is a malignant disease of the bone marrow that causes an increase in white blood cells and might not form distinctive tumors.. Myeloproliferative Disorders / Neoplasms Intro for the Internist Satish Shanbhag MBBS, MPH Assistant Professor of Medicine and Oncology Johns Hopkins University School of Medicine Objectives Internist focused review of the presentation, diagnostic workup, treatment and prognosis of the common myeloproliferative neoplasms Dr. Ali Khazaal Jumaa. F. .I.B.M.S (Int. Medicine), F.I.B.M.S (Hematology). . Definition. Myeloproliferative neoplasms (MPNs) are a heterogeneous group of disorders characterized by cellular proliferation of one or more hematologic cell lines.. characterised . by . overproduction of one or more myeloid cell types . via bone marrow stimulation. . Entities include;. Polycythaemia vera, (PV). Essential . thrombocythaemia . (ET). Primary . (idiopathic) . 23. Learning Objectives—Level I. At the end of this unit of study, the student should be able to:. Define and differentiate the terms . neoplasm. and . malignant. and identify hematopoietic disorders that can be included in each category.. MPNs) . Clinical . Trials. Anthony J. Messina. , . MSc. , CCRP . 1,2 . Quentin E. O’Brien. , MPH. 2*. . Vasily Andrianov. , MD. 1. . Keren R. Moss. , MD. 1*. . Laura Vidal. , MD. After receiving a request from the WTC Clinical Centers of Excellence to review certain myeloid disorders in terms of their status as malignancies, 1 the WTC Health Program has determined that, 2 e g yeloproliferative NeoplasmsInformation Guide https://www.cancersupportcommunity.org/sites/default/files/uploads/learn aboutcancer/cancertypes/Myelofibrosis/fsac_myelofibrosis.pdf o https://www.cancer This synopsis has been completed by medical practitioners. It is based on a literature search at the standard of a textbook of medicine and generalist review articles. It is not intended to be a meta- Robert J. Jacobson MD, FACP , FRCP(C).. Florida Cancer Specialists. Affiliate Professor of Biological Sciences. Charles E. Schmidt School of Medicine. Florida Atlantic University, Boca Raton, FL. 1. Stem Cells and .